Skip to content

The role of individualized respiratory parameter setting during anesthesia in lung protection

The role of individualized respiratory parameter setting during anesthesia in lung protection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108257
Enrollment
Unknown
Registered
2025-08-27
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic cholecystectomy under general anesthesia

Interventions

Control group:Mechanical ventilation was performed with a conventional tidal volume setting of 8 ml/kg
Experimental group:The tidal volume setting for mechanical ventilation is based on the measured value at the preoperative resting state

Sponsors

The Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: A total of 40 patients scheduled for elective laparoscopic cholecystectomy at the Affiliated Hospital of Inner Mongolia Medical University between August 2024 and January 2025 were enrolled. The patients ranged in age from 30 to 50 years, with a body mass index (BMI) between 18 and 24 kg/m^2 and were classified as American Society of Anesthesiologists (ASA) physical status I–II. Surgical duration was limited to within 1.5 hours

Exclusion criteria

Exclusion criteria: (1) hypoxemia (partial pressure of oxygen, PaO2 50 mmHg), or central hypoventilation syndrome; (2) a history of severe arrhythmia, significant cardiac, pulmonary, hepatic, or renal dysfunction, or circulatory instability with decompensated cardiac function; (3) coagulopathy (international normalized ratio [INR] > 1.5); (4) recent or uncontrolled infections or excessive airway mucus secretion; (5) patients assessed preoperatively by anesthesiologists as having difficult airway management or those at high risk for gastric content reflux or aspiration; (6) abnormal airway anatomy, previous tracheotomy, or lobectomy; (7) neurological disorders impairing cooperation; (8) intraoperative blood loss exceeding 1000 mL or vital sign fluctuations beyond the normal range requiring pharmacological intervention.

Design outcomes

Primary

MeasureTime frame
HTI56;SP-A;IL-6;TNF-a;

Countries

China

Contacts

Public ContactXin Wang

The Affiliated Hospital of Inner Mongolia Medical University

1339223830@qq.com+86 186 9842 5887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026